Triv Group Targets Hygiene Products Market, Backs MMIX Expansion
Triv Group founder Gabriel Rey said he was confident in the prospects of PT Multi Medika Internasional Tbk (MMIX), increasing his shareholding in the company by 530,000 lots.
Triv Group said it had invested around Rp80 billion to support MMIX’s business development, including its expansion in the hygiene products industry.
Gabriel said the investment decision was based on a combination of business fundamentals, market growth potential and management’s commitment to developing the company. In his view, investment depends not only on the industry’s prospects but also on the quality of the people running the business.
“When we invest in a company, the first thing we look at is the people and the management. After that, we look at the company itself,” Gabriel said at a press conference at PT Multi Nice Paper Indonesia’s factory in Legok, Tangerang Regency, Banten, on Thursday (15 October 2026).
He said MMIX’s management had the vision and commitment to grow the business. That confidence was one of the factors behind Triv Group’s decision to increase its shareholding and support the company’s expansion plans.
Gabriel stressed that Triv Group’s investment in MMIX was intended for the long term. As long as the business fundamentals remained sound and the company could carry out its growth strategy, he said he would hold on to the investment.
“As long as the business fundamentals do not change, I should not take profit. I will treat this as a long-term investment. What matters is that the business grows and the company’s development strategy is implemented,” he said.
Gabriel also sees attractive growth opportunities in Indonesia’s hygiene products industry, supported by the country’s large population and demand for everyday goods such as nappies, masks and personal care products.
He said one of Multi Medika’s advantages was its effort to build domestic production capacity, while some industry players still rely on imports.
According to Gabriel’s analysis, around 79% of the competitors reviewed still depend on imports. He said this creates an opportunity for local manufacturers to compete through cost efficiency, price control and stronger supply chains.
“With a local factory, production costs can be better controlled. The company is also less exposed to exchange-rate fluctuations than players that still rely on imports,” he said.
Gabriel added that pricing was particularly important in the fast-moving consumer goods (FMCG) industry. Consumers of products such as nappies tend to be sensitive to price changes, making production efficiency a key factor in competitiveness.
In addition to local production, he highlighted MMIX’s distribution network, which reaches modern retailers such as Indomaret and Alfamart, as well as traditional markets.
Distribution, Gabriel said, was one of the biggest challenges in consumer goods. Even quality products at competitive prices need broad market access to reach consumers effectively.
One issue he is watching is management’s reported preparations for a dual listing, or the listing of shares on more than one exchange.
Gabriel said access to international capital markets could broaden the investor base and create opportunities to secure liquidity from overseas.
“If we rely only on investment funds in the domestic market, liquidity is limited. A dual listing could give the company access to global liquidity,” he said.
He emphasised that growth in the business fundamentals should go hand in hand with the company’s capital-market development strategy.
Gabriel said companies that increase production capacity, expand their markets and maintain operational performance have a stronger foundation for building investor confidence over the long term.
However, the proposed dual listing still requires official clarification from management on which entity would be listed, the destination exchange and the implementation timetable.
Gabriel added that Triv Group’s investment in Multi Medika was expected to support the company’s expansion.
Beyond providing capital, the group sees opportunities to collaborate through its business network, particularly in developing distribution and strengthening the brand.
He also said Triv Group would remain focused on its core businesses in financial technology and wellness.
Looking ahead, the group sees opportunities to expand its business ecosystem, including potentially entering healthcare services and integrating Multi Medika products into its network.
In the hygiene products industry, Gabriel supports MMIX’s ambition to expand its market and improve the competitiveness of locally made products. He hopes the company will develop into one of Indonesia’s leading players.
“Our group always strives to be number one in every sector in which we invest. I hope Multi Medika can also become a leading producer of nappies, masks, beauty products and other categories in Indonesia,” he said.
Gabriel stressed that support for the company would not be limited to funding, but would also include opportunities for distribution collaboration and brand development.
Source: jawawa.id (https://jawawa.id/newsitem/triv-group-targets-hygiene-products-market-backs-mmix-expansion-1792140651)
Originally published by olenka.id (https://olenka.id/triv-group-bidik-potensi-bisnis-produk-higienitas-dukung-ekspansi-mmix/amp), translated from Indonesian